REGENERON PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
REGENERON PHARMACEUTICALS, INC. (REGN) reported Earnings Per Share, Basic and Diluted of -$0.58 per share for the 3-month period ending 2011-12-31, per its 10-K filed 2013-02-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2013-02-15
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2011-12-31 was -$0.58.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2011-09-30 was -$0.68.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2011-06-30 was -$0.69.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2011-03-31 was -$0.49.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2011 was -$2.45.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2010 was -$1.26.
- REGENERON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2009 was -$0.85.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$0.58 10-K · filed 2013-02-15 | -$2.45 10-K · filed 2012-02-21 | ||
| 2011-09-30 | -$0.68 10-K · filed 2013-02-15 | -$1.87 10-Q · filed 2011-10-27 | ||
| 2011-06-30 | -$0.69 10-K · filed 2013-02-15 | -$1.18 10-Q · filed 2011-07-28 | ||
| 2011-03-31 | -$0.49 10-K · filed 2013-02-15 | |||
| 2010-12-31 | -$0.17 10-K · filed 2012-02-21 | -$1.26 10-K · filed 2012-02-21 | ||
| 2010-09-30 | -$0.41 10-K · filed 2012-02-21 | -$1.10 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | -$0.31 10-K · filed 2012-02-21 | -$0.69 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$0.38 10-K · filed 2012-02-21 | |||
| 2009-12-31 | -$0.85 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |